Correlation Between SK Bioscience and MedPacto

Can any of the company-specific risk be diversified away by investing in both SK Bioscience and MedPacto at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SK Bioscience and MedPacto into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between SK Bioscience Co and MedPacto, you can compare the effects of market volatilities on SK Bioscience and MedPacto and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SK Bioscience with a short position of MedPacto. Check out your portfolio center. Please also check ongoing floating volatility patterns of SK Bioscience and MedPacto.

Diversification Opportunities for SK Bioscience and MedPacto

0.65

Correlation Coefficient

SK Bioscience  MedPacto

Poor diversification

The 3 months correlation between 302440 and MedPacto is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding SK Bioscience Co and MedPacto in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MedPacto and SK Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SK Bioscience Co are associated (or correlated) with MedPacto. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MedPacto has no effect on the direction of SK Bioscience i.e., SK Bioscience and MedPacto go up and down completely randomly.

Pair Corralation between SK Bioscience and MedPacto

Assuming the 90 days trading horizon SK Bioscience Co is expected to generate 1.13 times more return on investment than MedPacto. However, SK Bioscience is 1.13 times more volatile than MedPacto. It trades about 0.21 of its potential returns per unit of risk. MedPacto is currently generating about 0.02 per unit of risk. If you would invest  4,630,000  in SK Bioscience Co on September 20, 2024 and sell it today you would earn a total of  1,150,000  from holding SK Bioscience Co or generate 24.84% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

SK Bioscience Co  vs.  MedPacto

SK Bioscience

Risk-Adjusted Performance

3 of 100

Very Weak

Compared to the overall equity markets, risk-adjusted returns on investments in SK Bioscience Co are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, SK Bioscience may actually be approaching a critical reversion point that can send shares even higher in January 2025.

MedPacto

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days MedPacto has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with SK Bioscience and MedPacto

The main advantage of trading using opposite SK Bioscience and MedPacto positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SK Bioscience position performs unexpectedly, MedPacto can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MedPacto will offset losses from the drop in MedPacto's long position.

The idea behind SK Bioscience Co and MedPacto pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.